Trade Galectin Therapeutics Inc. - GALT CFD
What is Galectin Therapeutics Inc. (GALT)?
Galectin Therapeutics Inc. is a clinical-stage biotechnology company focused on the development of therapies targeting galectin proteins implicated in fibrotic diseases and cancer. The company’s research centers on inhibiting galectin-3, a protein involved in inflammation, fibrosis, and tumor progression. Galectin Therapeutics develops drug candidates intended to treat conditions such as liver fibrosis, cancer, and other fibrotic disorders. Its activities include preclinical studies, clinical trials, and regulatory interactions. The company collaborates with research institutions and industry partners to advance its therapeutic pipeline. Galectin Therapeutics operates within the biopharmaceutical sector, subject to regulatory oversight by agencies including the Food and Drug Administration. Its governance structure comprises a board of directors and executive leadership responsible for corporate strategy and compliance.
Galectin Therapeutics Inc. Stock Price Today: Live Overview
The price today is shaped by trading fluctuations, as Galectin Therapeutics Inc. is currently at $2.7084. The price range for the day spans from $2.5916 to $2.9016, with a daily change of -5.0512%.
FAQ: Galectin Therapeutics Inc. (GALT)
What is the current price of GALT stock?
The stock currently trades at $2.7084.
Does GALT pay dividends?
Galectin Therapeutics Inc. does not pay dividends.
Does GALT have a formal corporate presence or regional headquarters in the UAE?
Galectin Therapeutics Inc does not have a registered presence in the UAE and operates via partnerships.
What is GALT best known for?
The company is most famous for developing therapies targeting galectin proteins for fibrosis and cancer.
What assets are typically shown together with GALT?
Commonly shown alongside GALT: Volvo - B, ProShares Ultra SmallCap600, Banca Mediolanum S.p.A.
Latest shares articles



